Greg Towers

Citée par

	Toutes	Depuis 2019
Citations	14266	5833
indice h	62	35
indice i10	117	81

1400

700

350

1050

2002200320042005200620072008200920102011201220132014201520162017201820192020202120222023202446 100 309 327 402 376 403 354 536 732 731 745 671 603 639 575 667 716 791 846 942 1136 1389

Accès public

Tout afficher

83 articles

1 article

disponibles

non disponibles

Sur la base des exigences liées au financement

Coauteurs

Mahdad NoursadeghiUniversity College LondonAdresse e-mail validée de ucl.ac.uk
Adam J. FletcherMRC University of Glasgow Centre for Virus ResearchAdresse e-mail validée de glasgow.ac.uk
David JacquesSchool of Biomedical Sciences, University of New South Wales, AustraliaAdresse e-mail validée de unsw.edu.au
Ravindra Kumar GuptaUniversity of CambridgeAdresse e-mail validée de cam.ac.uk
Paul BieniaszProfessor, The Rockefeller universityAdresse e-mail validée de rockefeller.edu
William A McEwanUK Dementia Research Institute, University of CambridgeAdresse e-mail validée de cam.ac.uk
Paul KellamImperial College London & RQ Biotechnology LtdAdresse e-mail validée de imperial.ac.uk
Stephen P. GoffProfessor of Biochemistry and Molecular Biophysics, Columbia UniversityAdresse e-mail validée de cumc.columbia.edu
Vineet KewalRamaniNational Institutes of Health, USAAdresse e-mail validée de mail.nih.gov
Troy BradyUniversity of Pennsylvania, Iowa State UniversityAdresse e-mail validée de auburn.edu
Jeremy LubanUMass Med, Broad Institute of MIT and Harvard, Ragon Institute of MGH, MIT, & Harvard; MassCPRAdresse e-mail validée de umassmed.edu
Aris KatzourakisProfessor of Evolution and Genomics, University of OxfordAdresse e-mail validée de biology.ox.ac.uk
Jeremy GarsonUCLAdresse e-mail validée de ucl.ac.uk
Robert J. GiffordUniversity of GlasgowAdresse e-mail validée de glasgow.ac.uk
Jonathan Luke HeeneyProfessor of Comparative Pathology, University of CambridgeAdresse e-mail validée de cam.ac.uk
Yasuhiro ikedaExecutive Director, Cell Therapeutics and Viral Technologies, R&D, AstraZenecaAdresse e-mail validée de astrazeneca.com
Benny ChainUCLAdresse e-mail validée de ucl.ac.uk
Richard JennerProfessor of Molecular Biology, University College LondonAdresse e-mail validée de ucl.ac.uk
Julia G PradoIrsicaixaAdresse e-mail validée de irsicaixa.es
jason chin OR jason w. chin OR chin JWAdresse e-mail validée de mrc-lmb.cam.ac.uk

Suivre

Greg Towers

university college london

Adresse e-mail validée de ucl.ac.uk

virology


Titre Trier par citations Trier par année Trier par titre	Citée par Citée par	Année
SARS-CoV-2 variant biology: immune escape, transmission and fitness AM Carabelli, TP Peacock, LG Thorne, WT Harvey, J Hughes, SJ Peacock, ... Nature Reviews Microbiology 21 (3), 162-177, 2023	892	2023
Positional cloning of the mouse retrovirus restriction gene Fvl S Best, PL Tissier, G Towers, JP Stoye Nature 382 (6594), 826-829, 1996	608	1996
Antibodies mediate intracellular immunity through tripartite motif-containing 21 (TRIM21) DL Mallery, WA McEwan, SR Bidgood, GJ Towers, CM Johnson, ... Proceedings of the National Academy of Sciences 107 (46), 19985-19990, 2010	562	2010
HIV-1 capsid-cyclophilin interactions determine nuclear import pathway, integration targeting and replication efficiency T Schaller, KE Ocwieja, J Rasaiyaah, AJ Price, TL Brady, SL Roth, S Hué, ... PLoS pathogens 7 (12), e1002439, 2011	560	2011
HIV-1 evades innate immune recognition through specific cofactor recruitment J Rasaiyaah, CP Tan, AJ Fletcher, AJ Price, C Blondeau, L Hilditch, ... Nature 503 (7476), 402-405, 2013	536	2013
Cyclophilin A modulates the sensitivity of HIV-1 to host restriction factors GJ Towers, T Hatziioannou, S Cowan, SP Goff, J Luban, PD Bieniasz Nature medicine 9 (9), 1138-1143, 2003	503	2003
The human and African green monkey TRIM5α genes encode Ref1 and Lv1 retroviral restriction factor activities Z Keckesova, LMJ Ylinen, GJ Towers Proceedings of the National Academy of Sciences 101 (29), 10780-10785, 2004	439	2004
Evolution of enhanced innate immune evasion by SARS-CoV-2 LG Thorne, M Bouhaddou, AK Reuschl, L Zuliani-Alvarez, B Polacco, ... Nature 602 (7897), 487-495, 2022	412	2022
Restriction of lentivirus in monkeys C Besnier, Y Takeuchi, G Towers Proceedings of the National Academy of Sciences 99 (18), 11920-11925, 2002	384	2002
A conserved mechanism of retrovirus restriction in mammals G Towers, M Bock, S Martin, Y Takeuchi, JP Stoye, O Danos Proceedings of the National Academy of Sciences 97 (22), 12295-12299, 2000	329	2000
The control of viral infection by tripartite motif proteins and cyclophilin A GJ Towers Retrovirology 4, 1-10, 2007	309	2007
CPSF6 defines a conserved capsid interface that modulates HIV-1 replication AJ Price, AJ Fletcher, T Schaller, T Elliott, KE Lee, VN KewalRamani, ... Public Library of Science 8 (8), e1002896, 2012	305	2012
Restriction of multiple divergent retroviruses by Lv1 and Ref1 T Hatziioannou, S Cowan, SP Goff, PD Bieniasz, GJ Towers The EMBO journal, 2003	303	2003
HIV integration targeting: a pathway involving Transportin-3 and the nuclear pore protein RanBP2 KE Ocwieja, TL Brady, K Ronen, A Huegel, SL Roth, T Schaller, ... PLoS pathogens 7 (3), e1001313, 2011	270	2011
Independent evolution of an antiviral TRIMCyp in rhesus macaques SJ Wilson, BLJ Webb, LMJ Ylinen, E Verschoor, JL Heeney, GJ Towers Proceedings of the National Academy of Sciences 105 (9), 3557-3562, 2008	268	2008
TRIM22 inhibits influenza A virus infection by targeting the viral nucleoprotein for degradation A Di Pietro, A Kajaste-Rudnitski, A Oteiza, L Nicora, GJ Towers, N Mechti, ... Journal of virology 87 (8), 4523-4533, 2013	267	2013
HIV-1 uses dynamic capsid pores to import nucleotides and fuel encapsidated DNA synthesis DA Jacques, WA McEwan, L Hilditch, AJ Price, GJ Towers, LC James Nature 536 (7616), 349-353, 2016	250	2016
Mutation of a single residue renders human tetherin resistant to HIV-1 Vpu-mediated depletion RK Gupta, S Hué, T Schaller, E Verschoor, D Pillay, GJ Towers PLoS pathogens 5 (5), e1000443, 2009	222	2009
Disease-associated XMRV sequences are consistent with laboratory contamination S Hué, ER Gray, A Gall, A Katzourakis, CP Tan, CJ Houldcroft, S McLaren, ... Retrovirology 7, 1-10, 2010	212	2010
SARS‐CoV‐2 sensing by RIG‐I and MDA5 links epithelial infection to macrophage inflammation LG Thorne, AK Reuschl, L Zuliani‐Alvarez, MVX Whelan, J Turner, ... The EMBO journal 40 (15), e107826, 2021	201	2021

Le système ne peut pas réaliser cette opération maintenant. Veuillez réessayer plus tard.

Articles 1–20

Nombre de citations par an

Citations en double

Citations fusionnées

Ajouter les coauteursCoauteurs

Suivre

Citée par

Coauteurs